v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2023 103,426        
Balance at Dec. 31, 2023 $ 10 $ 126,047,945 $ 22,821 $ (125,007,210) $ 1,063,566
Issuance of common stock for directors’ fees (in shares) 1,205        
Issuance of common stock for directors’ fees $ 0 18,006 0   18,006
Issuance of restricted common stock to employees (in shares) 17,896        
Issuance of restricted common stock to employees $ 2 (2) 0 0 0
Forfeiture of restricted stock (in shares) (917)        
Forfeiture of restricted stock $ 0   0 0 (1)
Forfeiture of restricted stock   0      
Exercise of warrants (in shares) 190,322        
Exercise of warrants $ 19 1,908,080 0 0 1,908,099
Issuance of stock for securities purchase agreements (in shares) 59,500        
Issuance of stock for securities purchase agreements $ 6 4,999,994 0 0 5,000,000
Issuance of common stock for employee stock purchase plan (in shares) 264        
Issuance of common stock for employee stock purchase plan $ 0 3,690 0 0 3,690
Share based compensation for employee stock purchase plan 0 775 0 0 775
Other comprehensive income – Foreign translation adjustment 0 0 26,469 0 26,469
Share-based compensation 0 224,470 0 0 224,470
Issuance costs 0 (172,350) 0 0 (172,350)
Net loss 0 0 0 (4,300,692) (4,300,692)
Forfeiture of restricted stock   0      
Share-based compensation $ 0 224,470 0 0 224,470
Balance (in shares) at Dec. 31, 2024 371,696        
Balance at Dec. 31, 2024 $ 37 133,030,607 49,290 (129,307,902) 3,772,032
Issuance of common stock for directors’ fees (in shares) 2,314        
Issuance of common stock for directors’ fees $ 0 20,004 0 0 20,004
Issuance of restricted common stock to employees (in shares) 28,300        
Issuance of restricted common stock to employees $ 3 (3) 0 0 0
Forfeiture of restricted stock (in shares) (3,025)        
Forfeiture of restricted stock   0 0 0
Forfeiture of restricted stock        
Exercise of warrants (in shares) 515,278        
Exercise of warrants $ 52 6,966,506 0 0 6,966,558
Issuance of common stock for employee stock purchase plan (in shares) 2,125        
Issuance of common stock for employee stock purchase plan $ 0 10,076 0 0 10,076
Share based compensation for employee stock purchase plan 0 2,250 0 0 2,250
Other comprehensive income – Foreign translation adjustment 0 0 25,513 0 25,513
Share-based compensation 0 144,321 0 144,321
Issuance costs 0 (462,994) 0 0 (462,994)
Net loss $ 0 0 0 (7,157,946) (7,157,946)
Forfeiture of restricted stock        
Debt Conversion, Converted Instrument, Shares Issued (in shares) 168,672        
Issuance of stock for repayment of debt $ 17 1,786,974 0 0 1,786,991
Share-based compensation $ 0 144,321 0 144,321
Balance (in shares) at Dec. 31, 2025 1,085,360        
Balance at Dec. 31, 2025 $ 109 $ 141,497,741 $ 74,803 $ (136,465,848) $ 5,106,805